How does the MPEP define standard amino acids?

While the MPEP doesn’t directly define standard amino acids, it indirectly provides this information by referencing WIPO Standard ST.26. According to MPEP 2412.03(c): WIPO Standard ST.26, paragraph 3(e), identifies “modified amino acid” to mean any amino acid as described in the definition of “amino acid”, other than L-alanine, L-arginine, L-asparagine, L-aspartic acid, L-cysteine, L-glutamine, L-glutamic…

Read More

When is the MPEP 2412.05(c) guidance on sequence variants applicable?

The guidance provided in MPEP 2412.05(c) is applicable under specific conditions: “[Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]” This means that the requirements for representing sequence variants in the “Sequence Listing XML”…

Read More

When did the new rules for “modified amino acids” in patent applications come into effect?

The new rules regarding “modified amino acids” in patent applications came into effect on July 1, 2022. This is clearly stated in the MPEP 2412.03(c): [Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]…

Read More

Why are all sequences, claimed or not, required in patent applications?

All sequences, whether claimed or only disclosed, are required in patent applications for several important reasons. According to MPEP 2421.02: “All such sequences are relevant for the purposes of building a comprehensive database and properly assessing prior art. It is therefore essential that all sequences, whether only disclosed or also claimed, be included in the…

Read More

What regulation governs the requirements for patent applications with nucleotide and/or amino acid sequence disclosures?

The requirements for patent applications with nucleotide and/or amino acid sequence disclosures are governed by 37 CFR 1.831. This is referenced in MPEP 2412.03(c): 37 CFR 1.831 Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures. This regulation sets forth the specific requirements that patent applicants…

Read More